AU2001257160A1 - Methods and compositions for the diagnosis of schizophrenia - Google Patents
Methods and compositions for the diagnosis of schizophreniaInfo
- Publication number
- AU2001257160A1 AU2001257160A1 AU2001257160A AU5716001A AU2001257160A1 AU 2001257160 A1 AU2001257160 A1 AU 2001257160A1 AU 2001257160 A AU2001257160 A AU 2001257160A AU 5716001 A AU5716001 A AU 5716001A AU 2001257160 A1 AU2001257160 A1 AU 2001257160A1
- Authority
- AU
- Australia
- Prior art keywords
- schizophrenia
- diagnosis
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 201000000980 schizophrenia Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19889400P | 2000-04-21 | 2000-04-21 | |
| US60198894 | 2000-04-21 | ||
| PCT/US2001/013012 WO2001080716A2 (en) | 2000-04-21 | 2001-04-23 | Methods and compositions for the diagnosis of schizophrenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001257160A1 true AU2001257160A1 (en) | 2001-11-07 |
Family
ID=22735312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001257160A Abandoned AU2001257160A1 (en) | 2000-04-21 | 2001-04-23 | Methods and compositions for the diagnosis of schizophrenia |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001257160A1 (en) |
| WO (1) | WO2001080716A2 (en) |
-
2001
- 2001-04-23 WO PCT/US2001/013012 patent/WO2001080716A2/en not_active Ceased
- 2001-04-23 AU AU2001257160A patent/AU2001257160A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001080716A3 (en) | 2002-02-28 |
| WO2001080716A2 (en) | 2001-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| AU2001271973A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
| AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
| AU2002225894A1 (en) | Methods and compositions for the control of coccidiosis | |
| AU2001294556A1 (en) | Methods and compositions for the construction and use of fusion libraries | |
| AU2001255580A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001247196A1 (en) | Methods and compositions for detection of disease | |
| AU2001264522A1 (en) | Methods and compositions for the prevention of myopia | |
| AU2002249983A1 (en) | Compositions and methods for diagnosis of neuropsychiatric disorders | |
| AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
| AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
| AU2001257164A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257180A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257179A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001255597A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001255606A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001259127A1 (en) | Methods and composition for the diagnosis of schizophrenia | |
| AU2001259125A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001255585A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001255589A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257160A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257183A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257162A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257175A1 (en) | Methods and compositions for the diagnosis of schizophrenia |